Quick verdict
Hims & Hers is the better pick for most patients on overall scoring. Same-day prescription, no lock-in, and brand-name confidence. The famous $199 compounded era ended in March 2026 after the Novo Nordisk settlement; new patients now route to branded products only.
That said, Strut Health wins on specific dimensions. One of the cheapest legitimate compounded options in the US market thanks to a niche oral lozenge format. No membership fee, free shipping, free consults, and physician access included. Trade-off: lozenge bioavailability data is thin compared to standard injectable semaglutide.
Side-by-side
| Hims & Hers | Strut Health | |
|---|---|---|
| Starts from | $199/mo (incl. medication) | $99/mo (incl. medication) |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 1 day | 3 days |
| Consultation type | Asynchronous | Async |
| Affiliate network | Impact | Direct |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Hims & Hers | Strut Health | |
|---|---|---|
| Pricing transparency | 7/10 | 9/10 |
| Cancellation terms | 9/10 | 9/10 |
| Onboarding experience | 9/10 | 7/10 |
| Medication options | 7/10 | 6/10 |
| Member outcomes | 5/10 | 6/10 |
When to choose Hims & Hers
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable all-in monthly pricing.
When to choose Strut Health
Cost-sensitive patients who want needle-free GLP-1 entry under $100/mo and don't mind a less-studied delivery format.
FAQ
Is Hims & Hers cheaper than Strut Health?
Can I switch from Hims & Hers to Strut Health mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →